Next Article in Journal
Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis
Next Article in Special Issue
Antiviral Peptide-Based Conjugates: State of the Art and Future Perspectives
Previous Article in Journal
Bimodal Imaging of Tumors via Genetically Engineered Escherichia coli
Previous Article in Special Issue
Novel Cyclic Peptides for Targeting EGFR and EGRvIII Mutation for Drug Delivery
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(9), 1805; https://doi.org/10.3390/pharmaceutics14091805
Action Date Notes Link
article pdf uploaded. 27 August 2022 15:10 CEST Version of Record https://www.mdpi.com/1999-4923/14/9/1805/pdf-vor
article supplementary file uploaded. 27 August 2022 15:10 CEST - https://www.mdpi.com/1999-4923/14/9/1805#supplementary
article pdf uploaded. 29 August 2022 04:04 CEST Updated version of record https://www.mdpi.com/1999-4923/14/9/1805/pdf-vor
article xml file uploaded 7 September 2022 05:55 CEST Original file -
article xml uploaded. 7 September 2022 05:55 CEST Update https://www.mdpi.com/1999-4923/14/9/1805/xml
article pdf uploaded. 7 September 2022 05:55 CEST Updated version of record https://www.mdpi.com/1999-4923/14/9/1805/pdf
article html file updated 7 September 2022 05:56 CEST Original file -
article html file updated 28 February 2023 11:07 CET Update https://www.mdpi.com/1999-4923/14/9/1805/html
Back to TopTop